Medivir AB (publ) (STO:MVIR)
1.554
+0.054 (3.60%)
At close: Mar 6, 2026
Medivir AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Operating Revenue | 8.5 | 3.48 | 7.63 | 4.41 | 25.54 | Upgrade
|
| Other Revenue | - | - | - | - | 6.86 | Upgrade
|
| Revenue | 8.5 | 3.48 | 7.63 | 4.41 | 32.39 | Upgrade
|
| Revenue Growth (YoY) | 143.97% | -54.36% | 73.16% | -86.39% | 58.56% | Upgrade
|
| Cost of Revenue | 41.4 | 101.27 | 68.87 | 69.08 | 73.28 | Upgrade
|
| Gross Profit | -32.9 | -97.79 | -61.23 | -64.67 | -40.88 | Upgrade
|
| Selling, General & Admin | 27.1 | 27.16 | 27.37 | 20.74 | 21.42 | Upgrade
|
| Other Operating Expenses | 0.5 | 0.39 | 1.41 | 0.63 | -0.49 | Upgrade
|
| Operating Expenses | 60.1 | 30.28 | 31.52 | 23.94 | 23.52 | Upgrade
|
| Operating Income | -93 | -128.07 | -92.75 | -88.61 | -64.4 | Upgrade
|
| Interest Expense | -1.8 | -0.78 | -0.91 | -0.93 | -0.95 | Upgrade
|
| Interest & Investment Income | - | 0.07 | 0.03 | 0.01 | - | Upgrade
|
| Currency Exchange Gain (Loss) | - | 0.73 | 1.34 | 1.22 | 1.6 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.4 | - | 0 | - | 0 | Upgrade
|
| EBT Excluding Unusual Items | -94.4 | -128.05 | -92.3 | -88.31 | -63.75 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | 4.73 | 2.98 | -0.49 | 0.49 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | 0.04 | 0.68 | Upgrade
|
| Pretax Income | -94.4 | -123.32 | -89.32 | -88.77 | -62.58 | Upgrade
|
| Income Tax Expense | - | - | - | - | 0.55 | Upgrade
|
| Earnings From Continuing Operations | -94.4 | -123.32 | -89.32 | -88.77 | -63.13 | Upgrade
|
| Net Income | -94.4 | -123.32 | -89.32 | -88.77 | -63.13 | Upgrade
|
| Net Income to Common | -94.4 | -123.32 | -89.32 | -88.77 | -63.13 | Upgrade
|
| Shares Outstanding (Basic) | 143 | 114 | 60 | 56 | 53 | Upgrade
|
| Shares Outstanding (Diluted) | 143 | 114 | 60 | 56 | 53 | Upgrade
|
| Shares Change (YoY) | 25.08% | 88.71% | 8.44% | 5.53% | 117.45% | Upgrade
|
| EPS (Basic) | -0.66 | -1.08 | -1.48 | -1.59 | -1.20 | Upgrade
|
| EPS (Diluted) | -0.66 | -1.08 | -1.48 | -1.59 | -1.20 | Upgrade
|
| Free Cash Flow | -73.3 | -124.19 | -59.67 | -102.2 | -48.73 | Upgrade
|
| Free Cash Flow Per Share | -0.51 | -1.09 | -0.99 | -1.83 | -0.92 | Upgrade
|
| Gross Margin | - | - | - | - | -126.20% | Upgrade
|
| Operating Margin | -1094.12% | -3675.95% | -1215.16% | -2010.16% | -198.80% | Upgrade
|
| Profit Margin | -1110.59% | -3539.52% | -1170.21% | -2013.73% | -194.87% | Upgrade
|
| Free Cash Flow Margin | -862.35% | -3564.61% | -781.67% | -2318.56% | -150.44% | Upgrade
|
| EBITDA | -60.5 | -127.94 | -92.62 | -88.4 | -64.08 | Upgrade
|
| EBITDA Margin | - | - | - | - | -197.81% | Upgrade
|
| D&A For EBITDA | 32.5 | 0.13 | 0.14 | 0.2 | 0.32 | Upgrade
|
| EBIT | -93 | -128.07 | -92.75 | -88.61 | -64.4 | Upgrade
|
| EBIT Margin | - | - | - | - | -198.80% | Upgrade
|
| Revenue as Reported | 8.9 | 4.46 | 9 | 6.23 | 35.74 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.